Regenerative Medical Technology Group
Tracked across 6 events · 39 articles · First seen Jul 23, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Parent company executing strategic expansion into Argentina, expected to strengthen its Latin American presence.
Jul 23, 2026 · 6 articles
Business
Impact: RMTG is the central entity, hosting its first investor call to highlight strong first-half 2026 performance and engage shareholders. The event may enhance its credibility and investor relations.
Aug 05, 2026 · 9 articles
Business
Impact: RMTG is the central entity, having acquired the domain and launched the investor website as part of its investor-engagement strategy. This action may modestly improve shareholder communication and transparency.
Aug 26, 2026 · 6 articles
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Parent company announcing expansion; faces going-concern and liquidity issues.
Sep 08, 2026 · 6 articles
Business
Regenerative Medical Technology Group, Inc. (OTCID:RMTG) announced on September 17, 2026 the launch, through its ISSCA division, of a new Integrative Fellowship in Point-of-Care Regenerative Medicine. The fellowship is described as ISSCA's most comprehensive credential…
Impact: The company is the issuer of the announcement and the parent of Cell Stem Cell and ISSCA. The fellowship launch is intended to deepen physician relationships and create an educational pathway into ISSCA AI, but near-term financial impact is limited given the early commercialization stage.
Sep 17, 2026 · 6 articles
Business
Regenerative Medical Technology Group announced that its physician-education platform, the International Society for Stem Cell Application, will host the ISSCA 125 Global Summit from September 25-27, 2026 at the JW Marriott Cancun Resort and Spa…
Impact: The OTC-listed parent announced the summit through its subsidiary and frames it as a driver of physician education and commercial engagement. The event offers visibility but no disclosed financial figures, so any share-price effect is likely limited and sentiment-driven.
Sep 21, 2026 · 6 articles
70
Regenerative Medical Technology Group commenced commercial arrangements ColombiaRMTG Cellgenic expands...
70
Regenerative Medical Technology Group announced launchRMTG ISSCA Regenerative...
70
Regenerative Medical Technology Group announced summitRMTG ISSCA 125 Cancun Global Summit
Cell Stem Cell
parent
↔
Regenerative Medical Technology Group
Regenerative Medical Technology Group wholly owns Cell Stem Cell, which function
David Christensen
ceo
↔
Regenerative Medical Technology Group
David Christensen is the Chief Executive Officer and President of Regenerative M
Cell Stem Cell
subsidiary
↔
Regenerative Medical Technology Group
Cell Stem Cell is a wholly owned operating subsidiary of Regenerative Medical Te
ERGEN INTELLIGENCE
Track Regenerative Medical Technology Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard